======= NME1-NME2 ======= == Gene Information == * **Official Symbol**: N/A * **Official Name**: N/A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: N/A * **UniProt**: N/A * **Interactions**: [[https://thebiogrid.org/search.php?search=NME1-NME2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NME1-NME2|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Major role in the synthesis of nucleoside triphosphates other than ATP. Negatively regulates Rho activity by interacting with AKAP13/LBC. Acts as a transcriptional activator of the MYC gene; binds DNA non-specifically (PubMed:8392752). Exhibits histidine protein kinase activity. {ECO:0000269|PubMed:15249197, ECO:0000269|PubMed:20946858, ECO:0000269|PubMed:8392752}. |NDK| No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-2.35| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-1.87| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|-1.78| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-1.75| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-1.72| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.7| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.7| |[[:results:exp443|SNS-032 15μM R08 exp443]]|1.73| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|1.89| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 13807 * **Expression level (log2 read counts)**: 7.27 {{:chemogenomics:nalm6 dist.png?nolink |}}